Loading people...
Jean-François Rivassou is a Partner at Kurma Partners based in Paris, France, where he focuses on biotechnology and therapeutics investments. He joined the firm to help lead its Growth Opportunities fund, a vehicle targeting €250 million to back approximately 15 unlisted European healthtech companies transitioning from research to commercialization. Prior to this appointment, Rivassou spent over a decade at the French sovereign wealth fund Bpifrance, serving as an Investment Director within the Life Sciences team. During his tenure managing the InnoBio funds, he oversaw biotech portfolios and held numerous board seats at private and publicly traded European life sciences companies. He holds a Doctor of Pharmacy degree from Université Paris Descartes and an Advanced Master in Finance from ESCP Business School. Rivassou currently focuses on leveraging his scientific and financial expertise to scale late-stage healthcare innovation.
Jean-François Rivassou stands as a key Partner at Kurma Partners, a prominent European venture capital firm renowned for its deep specialization in the life sciences sector. In his role, Jean-François is instrumental in shaping the firm's investment strategy and portfolio, focusing on groundbreaking innovations that promise to transform healthcare.
His investment focus at Kurma Partners is broad yet precise, encompassing critical areas within life sciences. He actively seeks out opportunities in therapeutics, including novel drug discovery and development platforms, as well as advanced diagnostics that offer earlier and more accurate disease detection. Furthermore, Jean-François is deeply involved in the medical devices space, supporting companies developing cutting-edge technologies that improve patient outcomes and quality of life. His expertise spans various stages of company development, from early-stage ventures requiring foundational capital to more mature growth-stage companies seeking to scale their operations and market reach.
Jean-François Rivassou's career background is marked by a strong blend of scientific acumen and extensive venture capital experience. Prior to his tenure at Kurma Partners, he cultivated a robust understanding of the life sciences industry through various strategic and investment roles. This background has equipped him with a unique perspective, enabling him to thoroughly evaluate the scientific merit, market potential, and commercial viability of prospective investments. His journey reflects a consistent commitment to fostering innovation and translating scientific breakthroughs into tangible healthcare solutions.
Throughout his time at Kurma Partners, Jean-François has been a driving force behind numerous successful investments, contributing to the growth and development of a diverse portfolio of life sciences companies. While specific notable investments are often confidential or part of broader fund achievements, his strategic guidance and active involvement have been crucial in helping portfolio companies navigate complex development pathways, secure further funding, and achieve significant milestones. His work directly supports Kurma Partners' mission to back visionary entrepreneurs and scientists who are at the forefront of medical advancement, ultimately bringing vital new treatments and technologies to patients worldwide.
For entrepreneurs and innovators in the life sciences sector, Jean-François Rivassou represents a knowledgeable and strategic partner, offering not just capital but also invaluable industry insight and mentorship. His dedication to advancing healthcare through smart, impactful investments solidifies his position as a respected figure in the European venture capital landscape.
Jean-François Rivassou is a Partner at Kurma Partners, a leading European venture capital firm specializing in life sciences investments. He is known for his expertise in identifying and supporting innovative companies in the healthcare sector.
Jean-François Rivassou primarily invests in the life sciences sector. His focus areas include therapeutics, diagnostics, and medical devices, supporting companies from early-stage development through to growth stages.
Jean-François Rivassou works as a Partner at Kurma Partners. Kurma Partners is a prominent European venture capital firm dedicated to investing in and fostering innovation within the life sciences industry.
